CAMI PETERSON: Open Payments
NPI 1932986734 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$653 in 33 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $511 · 2025 $653
Food & beverage: $653
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $141 |
| ABBVIE INC. | 5 | $101 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| Lundbeck LLC | 2 | $49 |
| PFIZER INC. | 2 | $38 |
| Averitas Pharma Inc. | 1 | $30 |
| Axsome Therapeutics, Inc. | 2 | $29 |
| SANOFI-AVENTIS U.S. LLC | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| SHIELD THERAPEUTICS INC | 1 | $24 |
Products named: REXULTI, QULIPTA, TRELEGY ELLIPTA, VRAYLAR, QUTENZA, TZIELD, ROTATEQ, ACCRUFER.
Industry payments across UT — which companies pay providers there.
